MedPath

Trident Pharmaceuticals, Inc.

Trident Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.tridentpharma.com

Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteer Study
Interventions
Drug: HF1020 placebo
First Posted Date
2011-08-30
Last Posted Date
2011-10-31
Lead Sponsor
Trident Pharmaceuticals Inc
Target Recruit Count
32
Registration Number
NCT01425450
Locations
🇬🇧

Medicines Evaluation Unit, Manchester, Lancashire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath